How Type 2 Diabetes Medications Actually Work
Why one person thrives on one medication and another person feels wrecked.
Here’s something most people aren’t told upfront: Type 2 diabetes medications don’t all do the same thing.
They target different breakdowns in the glucose system—some help insulin work better, some push the pancreas harder, some slow digestion, and some tell the kidneys to dump sugar.
That’s why a medication can feel like a miracle for one person and absolute hell for another.
Understanding the mechanism doesn’t replace your healthcare provider—but it gives you the power to ask better questions
-
What This Article Is Really Saying:
Not: “Don’t take meds.”
But: “Know what problem the medication is trying to solve.
Ask Questions.”
When you understand this, you can stop blaming yourself and start collaborating intelligently with your providers.
Questions to Ask Your Provider:
“What part of my glucose system is
this medication targeting?”
“What signs would tell us this
isn’t the right match?”
“How does stress or sleep affect
how this medication works?”
“What should we reassess if side effects show up?”
The Missing Conversation:Most medication plans don’t assess:
Cortisol levels
Sleep quality
Chronic stress load
Nervous system state
Yet stress hormones can:Suppress insulin release
Increase liver glucose output
Worsen medication side effectsWhich is why a med that technically works can still feel intolerable—until nervous system regulation improves.
The RE²A²CH Method starts with a simple truth most treatment plans overlook: the nervous system is part of glucose regulation. Medications can improve signaling, insulin release, or glucose disposal—but chronic stress can quietly counteract those benefits.
When cortisol is high, the body prioritizes survival over balance. This is why the “right” medication can feel wrong until regulation improves. REACH supports women in reducing stress load, restoring safety in the body, and understanding their patterns—so medication becomes a support, not a struggle. -
1. Metformin
What it targets: Insulin resistance (primarily in the liver)
What it does:
Reduces how much glucose the liver
releases Improves insulin sensitivitySlightly reduces glucose absorption from food
Why it’s often first-line:
Long safety record
Doesn’t usually cause weight gain
Low risk of hypoglycemia
Why it can be brutal for some:
GI distress (nausea, diarrhea, cramps)
Can worsen fatigue if cortisol, gut health, or nutrient status is already compromised
Key question to ask:
“Is my issue more insulin resistance—or insulin production?
2. Sulfonylureas (e.g., Glimepiride)What they target: Insulin production (Phase 1 response)
What they do:
Signal the pancreas to release more insulin
Why they help some people dramatically:
Especially useful when the pancreas can make insulin but isn’t releasing it effectively
Risks & cautions:
Can cause low blood sugar
Can increase pancreatic workload over time
My lived insight (important):
For some women—especially those with stress-suppressed insulin release—this can feel like the missing piece until cortisol and nervous system load
are addressed.Key question to ask:
“Do I struggle more with insulin release or insulin resistance? Or both?"
-
3. GLP-1 Receptor Agonists injectables)
What they target: Appetite signaling, insulin response, digestion speed
What they do:
Increase insulin release only when glucose is present
Slow stomach emptying (smaller spikes)
Reduce appetite signaling in the brain
Why they’re powerful:
Improve glucose control and weight regulation
Lower cardiovascular risk
Why they’re not neutral:
Can cause nausea, fatigue, muscle loss if nutrition is inadequate
Appetite suppression ≠ metabolic healing by itself
Key question to ask:
“Is appetite dysregulation part of my glucose issue—or a response to stress?”
4. SGLT-2 InhibitorsWhat they target: Glucose excretion (via kidneys)
What they do:
Force excess glucose out through urine
Pros:
Lower blood sugar independently of insulin
Cardiovascular and kidney benefits for some
Cons:
Increased risk of dehydration and infections
Doesn’t address underlying insulin signaling
Key question to ask:
“Is this helping regulation—or just removing excess?”
5. DPP-4 Inhibitors (GLP-1 support, milder)What they target: Natural incretin hormones
What they do:
Help your own GLP-1 last longer
Why they’re gentler:
Less appetite suppression
Fewer GI effects
Trade-off:
More modest glucose lowering